Some people find it inappropriate or even rude to talk about money and business. We think those people are wrong, and on the fast-track to a lifetime of battling against Poverty. The way out? Education. If you travel abroad and don't speak the language, you are at a disadvantage. Yet here in the US, millions cannot understand the language that ultimately drives most decisions they make. Cash Talk is here so we can all better know the language of Money and Business. Enjoy and prosper.
Friday, August 19, 2005
Vioxx to cost Merck at least $250 million in jury case
According to this article, the wife of a man who died from taking Vioxx, a pain-killer, was awarded $253 million for lost wages, lost companionship and emotional anguish. While Merck should have tested their drug better, and the FDA obviously let the ball drop on approving this medicine, I think the award is significantly severe and a bit over the top. This case has obviously hurt Merck, as their shares dropped more than $2 to $28.06 today.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment